Lung cancer
Conditions
Interventions
Case series:None
Sponsors
Affiliated Hospital of Guangdong Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years, to ensure the patient has full civil capacity; 2. Pathologically confirmed diagnosis of lung adenocarcinoma; 3. Availability of complete clinical data, including basic information, symptom presentation, imaging examinations, pathological diagnosis reports, driver gene status, diagnostic staging, treatment plans, treatment efficacy evaluations, and traceable and usable follow-up data; 4. Patient agreement to participate in the study, with signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Presence of other significant comorbidities that severely impact survival or treatment evaluation and cannot be clearly distinguished from the treatment and prognosis of lung cancer; 2. Patients with severe mental illness or cognitive impairment who are unable to cooperate with treatment and follow-up; 3. Pregnant or lactating women, to avoid potential effects on the fetus or infant; 4. Participation in other clinical trials that may interfere with the assessment of treatment efficacy; 5. Patients with severe hepatic or renal dysfunction who cannot tolerate conventional treatment; 6. Patients with severe hematological diseases, such as severe anemia or coagulation disorders, which may affect treatment efficacy and safety; 7. Critical missing clinical data, such as unknown TNM staging, unknown treatment details (e.g., surgery, radiotherapy status), or unknown survival time, rendering the data unsuitable for effective analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AUC-ROC;Decision curve analysis, DCA;Progress Free Survival; | — |
Countries
China
Contacts
Public ContactYanli Mo
Affiliated Hospital of Guangdong Medical University
Outcome results
None listed